Lyndra Therapeutics is pioneering the first-ever oral, ultra-long-acting, sustained-release therapies, which have the potential to fundamentally change the way people take medicine by enabling patients to take a pill once a week rather than daily.

Biotechnology

Lyndra Therapeutics

Kiera Henderson

Richard Scranton

Lindsay Beaupre

Klas Holmlund, CFA

Anna Legedza

Patrick Boen

Jessica Ballinger

Erik Ryde

Jonathan Raber

Liah Dukaye

Morgan Foster

Nicholas Barner

Roman Lovell

Michelle O'Connor

Samuel Chadwick

Kevin Acreman

Rosemary Kanasty

Colin Gardner

Maureen Chlopik

Giovanni Traverso

Engineering and Scientific Research

Leadership Team

Clinical and Scientific Operations

Operations and Safety Team

Teams at Lyndra Therapeutics

Engineering and Scientific Research

Leadership Team

Clinical and Scientific Operations

Operations and Safety Team